Parents of babies with cystic fibrosis will soon have cheaper access to a life-saving drug.
From next month, Kalydeco will be subsidised on the Pharmaceutical Benefits Scheme.
The change is expected to save families up to $300,000 a year.
Federal Health Minister Greg Hunt says it’s life-changing.
“What Kalydeco can do is it can improve the capacity of these young children to breathe,” he says. “It gives them a better quality of life, it gives them a longer life, and ultimately it gives them access to further medicines that will help let them them live a rich, full life.”
Early intervention with the drug raises the life expectancy for cystic fibrosis sufferers.